IDH2 and glioblastoma: Zacher et al. used a 20-gene panel for an integrated histological and molecular diagnosis of 111 diffuse gliomas, allowing a re-classification of oligoastrocytoma and glioblastoma by IDH-status and identification of tumours with H3F3A mutations [104].